Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity
Emma C. Thomson, Laura E. Rosen, James G. Shepherd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 115

Showing 26-50 of 115 citing articles:

Development and deployment of COVID-19 vaccines for those most vulnerable
Wayne C. Koff, Theodore Schenkelberg, Tere Williams, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 579
Closed Access | Times Cited: 80
Status Report on COVID-19 Vaccines Development
Arun Kumar, William E. Dowling, Raúl Gómez Román, et al.
Current Infectious Disease Reports (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 78
Endemic SARS-CoV-2 will maintain post-pandemic immunity
Marc Veldhoen, J. Pedro Simas
Nature reviews. Immunology (2021) Vol. 21, Iss. 3, pp. 131-132
Open Access | Times Cited: 74
Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment
Mary Hongying Cheng, James Krieger, Burak Kaynak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 69
Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike
Bailey Lubinski, Maureen Hoch Vieira Fernandes, Laura E. Frazier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 67
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP
Laura Solforosi, Harmjan Kuipers, Mandy Jongeneelen, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 7
Open Access | Times Cited: 65
Monitoring Emergence of the SARS-CoV-2 B.1.1.7 Variant through the Spanish National SARS-CoV-2 Wastewater Surveillance System (VATar COVID-19)
Albert Carcereny, Adán Martínez-Velázquez, Albert Bosch, et al.
Environmental Science & Technology (2021) Vol. 55, Iss. 17, pp. 11756-11766
Open Access | Times Cited: 57
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
Gabriele Cerutti, Micah Rapp, Yicheng Guo, et al.
Structure (2021) Vol. 29, Iss. 7, pp. 655-663.e4
Open Access | Times Cited: 56
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 100991-100991
Open Access | Times Cited: 32
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Tyler N. Starr, Allison J. Greaney, Amin Addetia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 60
Covid-19 vaccines: delivering protective immunity
Herb F. Sewell, Raymond Agius, Denise Kendrick, et al.
BMJ (2020), pp. m4838-m4838
Open Access | Times Cited: 57
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
Cedric C.S. Tan, Su Datt Lam, Damien Richard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 53
SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview
Eleonora Cella, Francesca Benedetti, Silvia Fabris, et al.
Chemotherapy (2021) Vol. 66, Iss. 1-2, pp. 3-7
Open Access | Times Cited: 53
Zooanthroponotic potential of SARS-CoV-2 and implications of reintroduction into human populations
Arinjay Banerjee, Karen L. Mossman, Michelle L. Baker
Cell Host & Microbe (2021) Vol. 29, Iss. 2, pp. 160-164
Open Access | Times Cited: 52
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity
Thao Truong, Alex Ryutov, Utsav Pandey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46
Exploring the natural origins of SARS-CoV-2 in the light of recombination
Spyros Lytras, Joseph Hughes, Darren P. Martin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 45
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
Barbara Schrörs, Pablo Riesgo-Ferreiro, Patrick Sorn, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0249254-e0249254
Open Access | Times Cited: 41
Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2
Joachim Mariën, Johan Míchiels, Leo Heyndríckx, et al.
Journal of Virological Methods (2021) Vol. 297, pp. 114228-114228
Open Access | Times Cited: 36
A human coronavirus evolves antigenically to escape antibody immunity
Rachel Eguia, Katharine H. D. Crawford, Terry Stevens-Ayers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 36
Within-host genomics of SARS-CoV-2
Katrina Lythgoe, Matthew Hall, Luca Ferretti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 34
SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies
Ravindra K. Gupta, Dami A. Collier, Anna De Marco, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 28
Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
Kim Tien Ng, Nur Khairiah Mohd-Ismail, Yee‐Joo Tan
Vaccines (2021) Vol. 9, Iss. 2, pp. 178-178
Open Access | Times Cited: 28
Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
Faheem Hyder Pottoo, Tareq Abu‐Izneid, Abdallah Mohammad Ibrahim, et al.
Saudi Pharmaceutical Journal (2021) Vol. 29, Iss. 2, pp. 173-187
Open Access | Times Cited: 26
Role of SARS-CoV-2 and ACE2 variations in COVID-19
Priya Antony, Ranjit Vijayan
Biomedical Journal (2021) Vol. 44, Iss. 3, pp. 235-244
Open Access | Times Cited: 25
A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses
Bo Liu, Ying Yin, Yuxiao Liu, et al.
Engineering (2021) Vol. 13, pp. 107-115
Open Access | Times Cited: 25

Scroll to top